Novo Nordisk CEO defends lawsuit against Eli Lilly: ‘Competition has to be fair’
Novo Nordisk CEO defended the company’s decision to sue rival Eli Lilly over its weight-loss drug advertising. Source link
Tag: Business
Japan to announce Tokyo, Washington took joint action on yen, sources say | The Express Tribune
Finance minister Satsuki Katayama reportedly to confirm move Monday, first such effort since 2011 Japanese Finance Minister Satsuki Katayama will announce on Monday that Tokyo and Washington took joint action in the currency market to arrest the yen’s slide to 40-year lows, two Japanese government officials told Reuters. Katayama is likely to stress the two countries’ determination to combat what they consider…
Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline
Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart drug trial failed to reduce major adverse cardiovascular events, or MACE, compared to a placebo. While the experimental medicine, ziltivekimab, did show some biological effect, it didn’t translate into a statistically meaningful reduction in MACE, defined as…
Fat cat? Weight-loss drugs may be coming for your overweight pet
A beautiful, but over weight Maine Coon Cat gets measured around the belly by a vet. Ryersonclark | E+ | Getty Images Felix is five years old, loves food, and refuses to lose weight. His owner, Amy in Dallas, has tried cutting back on meals, but with two cats in the house, “he just gobbles…
Read More “Fat cat? Weight-loss drugs may be coming for your overweight pet” »
Jim Cramer says this former Covid market darling is finally investable again
Moderna’s expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty following the Covid-19 pandemic, CNBC’s Jim Cramer said Wednesday. “For the first time in a long time, the company seems like it has something to get excited about,” the “Mad Money” host said, before advising…
Read More “Jim Cramer says this former Covid market darling is finally investable again” »
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout the research process. “The value of AI in our industry is productivity improvement,” Soriot said on CNBC’s “Mad Money” on Friday. “In the way you design a new medicine, a new drug, you can actually do it…
Aramco CEO warns 1 billion barrels lost will slow oil market recovery | The Express Tribune
Saudi energy giant posts 25% jump in quarterly profit even as Hormuz blockade chokes global oil supplies Aramco’s President and CEO Amin Nasser at the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, on January 20, 2026. PHOTO: REUTERS The world has lost about 1 billion barrels of oil over the past two…
Planet Fitness stock plunges 30% after company slashes guidance, cancels planned price hikes
People work out at a Planet Fitness in Alexandria, Virginia, on Jan. 8, 2024. Leah Millis | Reuters Shares of Planet Fitness plunged more than 30% Thursday after the company reported a drag on sign-ups and trimmed its guidance. The stock was having its worst day ever, as of midday trading. Even though the fitness…
Gold prices in Pakistan Today – April 14, 2026 | The Express Tribune
At current prices, the looted gold is worth around $70 million. PHOTO: PIXABAY Gold rose more than 1% on Tuesday, recovering from a near one-week low hit in the previous session, as hopes of a resolution to the war in Iran weighed on the dollar and eased inflation concerns as oil prices eased. Spot gold…
Read More “Gold prices in Pakistan Today – April 14, 2026 | The Express Tribune” »
Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and drug-pricing…
Read More “Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era” »